[go: up one dir, main page]

FI940787L - Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa - Google Patents

Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa Download PDF

Info

Publication number
FI940787L
FI940787L FI940787A FI940787A FI940787L FI 940787 L FI940787 L FI 940787L FI 940787 A FI940787 A FI 940787A FI 940787 A FI940787 A FI 940787A FI 940787 L FI940787 L FI 940787L
Authority
FI
Finland
Prior art keywords
administering
time
dosage form
short period
drug over
Prior art date
Application number
FI940787A
Other languages
English (en)
Swedish (sv)
Other versions
FI940787A7 (fi
FI940787A0 (fi
Inventor
George V Guittard
Howard A Carpenter
Ernest S Quan
Patrick S-L Wong
Lawrence G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FI940787L publication Critical patent/FI940787L/fi
Publication of FI940787A7 publication Critical patent/FI940787A7/fi
Publication of FI940787A0 publication Critical patent/FI940787A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI940787A 1991-08-19 1992-08-19 Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa FI940787A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/747,899 US5178867A (en) 1991-08-19 1991-08-19 Dosage form for delivering drug in short-time period
PCT/US1992/007034 WO1993003711A1 (en) 1991-08-19 1992-08-19 Dosage form for delivering drug in short-time period

Publications (3)

Publication Number Publication Date
FI940787L true FI940787L (fi) 1994-02-18
FI940787A7 FI940787A7 (fi) 1994-02-18
FI940787A0 FI940787A0 (fi) 1994-02-18

Family

ID=25007151

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940787A FI940787A0 (fi) 1991-08-19 1992-08-19 Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa

Country Status (17)

Country Link
US (1) US5178867A (fi)
EP (1) EP0600033B1 (fi)
JP (1) JP2934505B2 (fi)
AT (1) ATE129404T1 (fi)
AU (1) AU666674B2 (fi)
CA (1) CA2112679C (fi)
DE (1) DE69205687T2 (fi)
DK (1) DK0600033T3 (fi)
ES (1) ES2079206T3 (fi)
FI (1) FI940787A0 (fi)
GR (1) GR3017891T3 (fi)
MX (1) MX9204776A (fi)
NO (1) NO940376L (fi)
NZ (1) NZ244009A (fi)
PT (1) PT100789A (fi)
WO (1) WO1993003711A1 (fi)
ZA (1) ZA926241B (fi)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO1995001782A2 (en) * 1993-07-09 1995-01-19 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5536505A (en) * 1993-12-15 1996-07-16 Eastman Chemical Company Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
US5523095A (en) * 1993-12-15 1996-06-04 Eastman Chemical Company Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
DE69631981T2 (de) * 1995-09-21 2005-04-14 Pharma Pass Ii Llc, Irvine Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren
AU7375598A (en) * 1997-05-09 1998-11-27 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
ZA9810765B (en) * 1998-05-28 1999-08-06 Ranbaxy Lab Ltd Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole.
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US7094426B2 (en) * 1998-08-27 2006-08-22 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6326384B1 (en) * 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US6669954B2 (en) 2000-01-25 2003-12-30 John R. Crison Controlled release of drugs
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
AU2002230830A1 (en) 2000-11-03 2002-05-15 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
EP1539144B1 (en) 2002-09-20 2014-12-24 Andrx Labs Llc Multistage formulation containing a biguanide and a thiazolidinedione derivative
WO2004066924A2 (en) * 2003-01-24 2004-08-12 Andrx Labs Llc Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US7051606B2 (en) * 2004-01-30 2006-05-30 Andrx Labs Llc Dosage form holder device and methods for immersion testing
CA2570916C (en) * 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
US20060276501A1 (en) * 2005-05-25 2006-12-07 Transoral Pharmaceuticals, Inc. Solid compositions for treating middle-of-the-night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
DE102005031577A1 (de) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
WO2009049160A1 (en) * 2007-10-12 2009-04-16 Takeda Pharmaceuticals North America Methods of treating gastrointestinal disorders independent of the intake of food
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
MX2014013320A (es) 2012-05-07 2015-08-10 Bayer Pharma AG Procedimiento de fabricacion de una forma de dosificacion farmaceutica que comprende nifedipina y candesartan cilexetilo.
PT4037666T (pt) 2020-12-08 2024-06-25 Ruminant Biotech Corp Ltd Aperfeiçoamentos de dispositivos e métodos para administração de substâncias a animais

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4519801A (en) 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
EP0247709B1 (en) * 1986-04-17 1991-01-02 Alza Corporation Chlorpheniramine therapy
US4948592A (en) * 1986-05-09 1990-08-14 Alza Corporation Pulsed drug delivery
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
NZ226822A (en) * 1987-11-16 1990-03-27 Mcneil Consumer Prod Chewable medicament tablet containing means for taste masking
US4931285A (en) * 1988-04-28 1990-06-05 Alza Corporation Aqueous based pharmaceutical coating composition for dosage forms

Also Published As

Publication number Publication date
AU666674B2 (en) 1996-02-22
PT100789A (pt) 1994-05-31
US5178867A (en) 1993-01-12
ATE129404T1 (de) 1995-11-15
JP2934505B2 (ja) 1999-08-16
EP0600033A1 (en) 1994-06-08
MX9204776A (es) 1993-04-01
ES2079206T3 (es) 1996-01-01
DE69205687D1 (de) 1995-11-30
NO940376D0 (no) 1994-02-07
JPH06509809A (ja) 1994-11-02
CA2112679A1 (en) 1993-03-04
DE69205687T2 (de) 1996-04-11
NO940376L (no) 1994-02-07
WO1993003711A1 (en) 1993-03-04
AU2544992A (en) 1993-03-16
FI940787A7 (fi) 1994-02-18
ZA926241B (en) 1993-10-04
GR3017891T3 (en) 1996-01-31
FI940787A0 (fi) 1994-02-18
NZ244009A (en) 1995-02-24
EP0600033B1 (en) 1995-10-25
CA2112679C (en) 2003-04-15
DK0600033T3 (da) 1995-12-27

Similar Documents

Publication Publication Date Title
FI940787L (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
FI924247A7 (fi) Annostusmuoto lääkkeen vapauttamiseksi suoleen
FI940850A7 (fi) Laite lääkkeen annostelemiseksi ihon kautta
KR950700754A (ko) 신규의 약물(novel medicament)
PT100973A (pt) Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
GB9016789D0 (en) Medicament administering devices
DE69224941D1 (de) Arzneimittelabgabekatheter
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
FI951879A7 (fi) Lääkkeiden injektointikatetri
DK0515312T3 (da) Farmaceutisk præparat
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
FI930737A7 (fi) Asialoglykoproteiiniin sidottu lääkeaine
NO302216B1 (no) Farmasöytisk doseringsform med nullte ordens frigivelse av en kalsiumantagonist av dihydropyridintypen
DE69326539D1 (de) Zytotoxische arzneimittel therapie
FI905684A7 (fi) Farmaseuttinen annosmuoto kalojen lääkintään
FI924456A7 (fi) Lääke
FI913608A7 (fi) Annosmuoto kalsiumantagonistin annostelemiseksi
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE69217020D1 (de) Arzneimittel mit gesteuerter Wirkstoffabgabe
FI923662L (fi) Terapeutiska medel
NO306381B1 (no) Farmasöytisk ampulle
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten

Legal Events

Date Code Title Description
FD Application lapsed